TICKERNOMICS Sign up
Last Update: 2024-03-28 02:09:30
HOLOGIC INC ( HOLX ) https://www.hologic.com
76.26USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-3.26%
HOLX
SPY
32.74%
HOLX
3.87%
SPY
92.93%
HOLX
57.56%
SPY
224.41%
HOLX
262.97%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
18646.49
19274.49
2.32
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
25.10
4.64
3.72
4.80
0.00
22.11
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
19.56
56.02
21.96
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.8952
12.10
9.57
1.24
Other Earnings and Cash Flow Stats:
HOLOGIC INC ( HOLX ) Net Income TTM ($MM) is 611.90
HOLOGIC INC ( HOLX ) Operating Income TTM ($MM) is 734.10
HOLOGIC INC ( HOLX ) Owners' Earnings Annual ($MM) is 981.02
HOLOGIC INC ( HOLX ) Current Price to Owners' Earnings ratio is 17.93
HOLOGIC INC ( HOLX ) EBITDA TTM ($MM) is 1017.90
HOLOGIC INC ( HOLX ) EBITDA Margin is 21.96%
Capital Allocation:
HOLOGIC INC ( HOLX ) has paid 0.00 dividends per share and bought back 2.373 million shares in the past 12 months
HOLOGIC INC ( HOLX ) has reduced its debt by 308.2 million USD in the last 12 months
Capital Structure:
HOLOGIC INC ( HOLX ) Interest-bearing Debt ($MM) as of last quarter is 2560
HOLOGIC INC ( HOLX ) Annual Working Capital Investments ($MM) are 713
HOLOGIC INC ( HOLX ) Book Value ($MM) as of last quarter is 5016
HOLOGIC INC ( HOLX ) Debt/Capital as of last quarter is 55%
Other Balance Sheet Stats:
HOLOGIC INC ( HOLX ) has 1932 million in cash on hand as of last quarter
HOLOGIC INC ( HOLX ) has 899 million of liabilities due within 12 months, and long term debt 2560 as of last quarter
HOLOGIC INC ( HOLX ) has 246 common shares outstanding as of last quarter
HOLOGIC INC ( HOLX ) has 0 million USD of preferred stock value
Academic Scores:
HOLOGIC INC ( HOLX ) Altman Z-Score is 4.17 as of last quarter
HOLOGIC INC ( HOLX ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
HOLOGIC INC ( HOLX ) largest shareholder is Millennium Management LLC owning 2058622 shares at 156.99 ($MM) value
GARRETT SCOTT T(an insider) Sold 16441 shares of HOLOGIC INC ( HOLX ) for the amount of $1241295.50 on 2024-03-14
0.73% of HOLOGIC INC ( HOLX ) is held by insiders, and 99.40% is held by institutions
HOLOGIC INC ( HOLX ) went public on 1990-06-21
Other HOLOGIC INC ( HOLX ) financial metrics:
FCF:859.30
Unlevered Free Cash Flow:-58.80
EPS:-0.66
Operating Margin:19.56
Gross Profit Margin:56.02
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:21.19
Beta:1.24
Buffet's Owners Earnings:981.02
Price to Owner's Earnings:17.93
About HOLOGIC INC ( HOLX ) :
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. wa
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.